Navigation Links
Celiac Disease Sufferers See an End to their Misery

Celiac disease sufferers often endure a life of dietary restrictions, ensuring that no gluten, a product found in many commonly eaten foods//, ever passes their lips.

But this may soon come to an end. Researchers in the Netherlands have found that an enzyme originally developed for commercial food processing -- AN-PEP -- may be able to break down gluten in the stomach before it reaches the small intestine. This information could be vital because the small intestine is where celiac disease originates.

According to the study's lead author, Frits Konig, professor of immunology at Leiden University Medical Center "There is a realistic chance that this enzyme can be used to develop an alternative treatment for celiac disease. It is very difficult to predict if such an enzyme-based treatment would actually be preferred over a gluten-free diet, but at the very least, it would provide patients with the option to occasionally follow a normal diet -- for example, when going out or during other social occasions, times when a gluten-free diet is certainly bothersome.

The results of the research have been published in the online journal American Journal of Physiology - Gastrointestinal and Liver Physiology. .

According to Konig about 1 percent of people in the United States and Europe are affected by celiac disease which is an autoimmune disease. It occurs when the body mistakes gluten molecules as foreign invaders to be destroyed. As a result parts of the small intestine are also destroyed along with the gluten moleculesduring the immune system response. This leads to a difficulty for the small intestine to properly absorb nutrients from food causing anemia and vitamin deficiencies. .

Therefore the only solution for avoiding the flare up of this disease would be to avoid gluten completely. However this is not an easy task. As Konig pointed out, "Gluten is a common protein found in wheat and related cereals like barley and rye. This means many common food products, like bread, breakfast cereals, pasta, cookies, etc., are forbidden. Moreover, gluten is often used as an additive in the food industry, so, many products that are not normally associated with wheat may contain gluten"..

As there is no animal model for celiac disease, treatments cannot be studied in animals. .

Konig said, "AN-PEP is very efficient and completely breaks down gluten proteins into fragments that are so small that they can no longer cause inflammation in the intestine. This we have also demonstrated by using white blood cells from patients that respond to gluten and cause inflammation in the intestine. These cells no longer respond to gluten when it has been treated with the AN-PEP enzyme"..

According to Konig AN-PEP is derived from Aspergillus niger, a common fungus. Since Aspergillus niger is already used in commercial food processing, he said side effects were unlikely from the treatment.

Konig said the next step is to conduct human trials.


'"/>




Related medicine news :

1. Celiac Disease in Type 1 Diabetes
2. Research on Celiac Disease in children
3. Understanding The Link Between Celiac Disease And Osteoporosis
4. Scientists Discover Non-dietary Therapy For Celiac Diseases
5. Center for Celiac Disease Opens
6. Potential Link Between Celiac Disease and Cognitive Decline
7. Prevalence of Celiac disease in children with type 1 diabetes
8. From the frying pan into the fire: Celiac disease and diabetes
9. Gluten Free Bread: Boon for Celiac Disease
10. Research Finds No Link Found Between Autism and Celiac Disease
11. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... NJ (PRWEB) , ... December 09, 2016 , ... ... Founders Ball at The Pierre Hotel in New York, NY, on December 3rd, ... benefactors, dignitaries and physicians attended the annual event, which raised over $1 million ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology: